Shalby Ltd Share Price – NSE  /  BSE

Healthcare, Small Cap

The equity stake will be acquired within a period of one month, through secondary buy‐outs.

This investment is in continuation with Shalby’s strategy to consolidate asset base for its recent acquisition of Sanar International Hospital (P K Healthcare) at Gurugram.

Sanar International Hospital is currently operating under leased land held by Healers Hospital. With this acquisition, Shalby has changed its business model from leased model to owned model for its recent acquisition of Sanar International Hospital in Jan 2024.

With this acquisition, the company will unlock the consolidated profitability of the group to the tune of leased rentals expense, ensure the lifelong continuity of Sanar Hospital at owned land model and also unlock the future value of asset being present at a prime location i.e. Golf Course Road, Gurugram.

Shalby is a company engaged in healthcare delivery space and listed with bourses in India. The company operates as a chain of multispecialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations etc

The company's consolidated net profit increased 24.72% to Rs 19.07 crore on 6.71% rise in net sales to Rs 216.05 crore in Q3 FY24 over Q3 FY23.

The scrip fell 0.33% to trade at Rs 229.45 on the BSE.

Powered by Capital Market - Live News

Net profit of Shalby rose 24.72% to Rs 19.07 crore in the quarter ended December 2023 as against Rs 15.29 crore during the previous quarter ended December 2022. Sales rose 6.71% to Rs 216.05 crore in the quarter ended December 2023 as against Rs 202.46 crore during the previous quarter ended December 2022.

Powered by Capital Market - Live News

Shalby will hold a meeting of the Board of Directors of the Company on 7 February 2024.

Powered by Capital Market - Live News

Shalby announced that the Board of Directors of Companyfs Wholly]owned Subsidiary Mars Medical Devices (MMDL) has, at its meeting held today i.e. 18 December 2023 approved to invest 2,00,000 Preference Shares of SGD 1 each in Shalby Global Technologies, Singapore (SGTPL).

SGTPL is a subsidiary of Mars Medical Devices and a Step]down Subsidiary of the Company. With the aforesaid investment, preference shareholding of MMDL in SGTPL will be 100% and there will not beany change in equity shareholding and remained at 99.33%.

Powered by Capital Market - Live News